OncoMed, Celgene To Jointly Advance Multiple Anti-Cancer Stem Cell … – NASDAQ
OncoMed, Celgene To Jointly Advance Multiple Anti-Cancer Stem Cell …NASDAQ(RTTNews.com) – OncoMed Pharmaceuticals, Inc. ( OMED ) and Celgene Corp. ( CELG ) announced an agreement to jointly develop and commercialize up to six anti-cancer stem cell or CSC product candidates from OncoMed’s biologics pipeline, including …Celgene commits $3.3B in whopper cancer stem cell deal … Continue reading
